drugset
drugset / Trial / NCT07596589

Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU

NCT07596589 ↗

Phase 3 Recruiting 80 enrolled Southeast University, China
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to evaluate the effect of remimazolam sedation on outcomes of mechanically ventilated ICU patients through a single-center, prospective, randomized controlled, pilot study.

Timeline

Start
2025-04-01
Primary completion
2027-01-31
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 0.3 mg/kg —
Subject Remimazolam Small molecule 0.2 mg/kg Intravenous

Indications

No indication recorded.